NBT Bank N A NY Acquires 360 Shares of Intuitive Surgical, Inc. $ISRG

NBT Bank N A NY increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.8% during the second quarter, Holdings Channel.com reports. The firm owned 3,422 shares of the medical equipment provider’s stock after buying an additional 360 shares during the period. NBT Bank N A NY’s holdings in Intuitive Surgical were worth $1,860,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Nuveen LLC bought a new position in shares of Intuitive Surgical during the first quarter valued at approximately $1,715,899,000. Goldman Sachs Group Inc. boosted its stake in shares of Intuitive Surgical by 26.1% during the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock valued at $1,396,496,000 after purchasing an additional 584,375 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Intuitive Surgical by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock valued at $1,680,922,000 after purchasing an additional 566,979 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after purchasing an additional 457,080 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in shares of Intuitive Surgical by 1.4% during the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after purchasing an additional 453,335 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director directly owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 over the last 90 days. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Up 1.6%

NASDAQ ISRG opened at $448.09 on Thursday. The company has a fifty day simple moving average of $460.50 and a two-hundred day simple moving average of $499.05. The stock has a market cap of $160.63 billion, a P/E ratio of 62.50, a P/E/G ratio of 4.64 and a beta of 1.61. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. During the same quarter last year, the company posted $1.78 earnings per share. The business’s quarterly revenue was up 21.4% on a year-over-year basis. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Piper Sandler restated an “overweight” rating and issued a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, October 4th. Evercore ISI lowered their target price on shares of Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a research note on Tuesday. Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Fourteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $589.43.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.